Taisei Shimada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taisei Shimada has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Daiki Setoyama
Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka, Japan
1 shared publication - Eriko Kage-Nakadai
Graduate School of Human Life and Ecology, Osaka Metropolitan University Department of Nutrition Osaka
1 shared publication - Fumi Nagatsugi
Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Japan
1 shared publication - Hidenori Okamura
Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , 1-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530
1 shared publication - Masaru Tanaka
Kyushu University
1 shared publication - Michiharu Kawahara
Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
1 shared publication
Latest Publications
- Open Access
A nucleic acid prodrug that activates mitochondrial respiration, promotes stress resilience, and prolongs lifespan
Mitochondrial dysfunction caused by aging leads to decreased energy metabolism, resulting in functional decline and increased frailty in multiple tissues. Strategies for protecting and activating mitochondria under stressful conditions are required to suppress aging and age-related diseases. However, it is challenging to develop drugs capable of boosting mitochondrial respiration and compensating for the reduced intracellular adenosine triphosphate (ATP) levels. In this study, we developed a prodrug that stimulates the metabolism of intracellular adenine nucleotides (AXP: adenosine monophosphate (AMP), adenosine diphosphate (ADP), and ATP). It enhances AMP-activated protein kinase activity, fatty acid oxidation, oxidative stress resistance, and mitochondrial respiration, thereby increasing the intracellular ATP levels. Furthermore, this prodrug markedly extended the lifespan of Caenorhabditis elegans . AXP-driven stimulation of cellular energy metabolism proposed herein represents a novel geroprotective strategy and paves the way for the development of bioenergetic-molecule therapeutics.
Open AccessA nucleic acid prodrug that activates mitochondrial respiration, promotes stress resilience, and prolongs lifespan
Mitochondrial dysfunction caused by aging leads to decreased energy metabolism, resulting in functional decline and increased frailty in multiple tissues. Strategies for protecting and activating mitochondria under stressful conditions are required to suppress aging and age-related diseases. However, it is challenging to develop drugs capable of boosting mitochondrial respiration and compensating for the reduced intracellular adenosine triphosphate (ATP) levels. In this study, we developed a prodrug that stimulates the metabolism of intracellular adenine nucleotides (AXP: adenosine monophosphate (AMP), adenosine diphosphate (ADP), and ATP). It enhances AMP-activated protein kinase activity, fatty acid oxidation, oxidative stress resistance, and mitochondrial respiration, thereby increasing the intracellular ATP levels. Furthermore, this prodrug markedly extended the lifespan of Caenorhabditis elegans . AXP-driven stimulation of cellular energy metabolism proposed herein represents a novel geroprotective strategy and paves the way for the development of bioenergetic-molecule therapeutics.